Market Place
Sourcing Support
BioRestorative Reports Positive Phase 2 BRTX-100 Data
13 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Therapies to Present Clinical Data at PSRS Symposium
06 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Receives Expanded Tissue License from NY Health Dept
05 Nov 2024 //
GLOBENEWSWIRE
BioRestorative Receives Patent Allowance for ThermoStem® Program
31 Oct 2024 //
GLOBENEWSWIRE
BioRestorative Participate UBS And Maxim Group Investor Events
10 Oct 2024 //
GLOBENEWSWIRE
BioRestorative To Join 3rd Annual ROTH Healthcare Opportunities Conf
03 Oct 2024 //
GLOBENEWSWIRE
BioRestorative Therapies To Present ThermoStem® At IFATS 2024
19 Sep 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Reports Q2 2024 Results And Business Update
13 Aug 2024 //
GLOBENEWSWIRE
BioRestorative Therapies To Report Q2 2024 Results On August 13
06 Aug 2024 //
GLOBENEWSWIRE
BioRestorative`s Chief Scientist Named Editor Of Translational Medicine Journal
23 Jul 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Notice of Allowance for Patent Covering
27 Jun 2024 //
GLOBENEWSWIRE
BioRestorative Regains Compliance With Nasdaq Rule; Reports Q1 2024 Results
17 Jun 2024 //
GLOBENEWSWIRE
BioRestorative Therapies In Discussions For ThermoStem License
13 Jun 2024 //
GLOBENEWSWIRE
BioRestorative: Attending Jefferies 2024 Healthcare Conference
04 Jun 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Receipt of Nasdaq Non-Compliance Notice
24 May 2024 //
GLOBENEWSWIRE
BioRestorative Partners With Cartessa, Enters $75B Aesthetics Market
15 May 2024 //
ACCESSWIRE
BioRestorative Therapies Provides First Quarter 2024 Business Update
14 May 2024 //
GLOBENEWSWIRE
BioRestorative Exosome Therapy For Obesity Program
08 May 2024 //
GLOBENEWSWIRE
BioRestorative, Cartessa Commercial Aesthetics Tech Deal
30 Apr 2024 //
GLOBENEWSWIRE
BioRestorative To Report Q1 2024 Results, Host Call On May 14
30 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Receives FDA Clearance for BRTX-100 Phase 2 Protocol Amendment
16 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Partners with Galen for Ph 2 Trial of BRTX-100
08 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Announces Filing of Form S-1 Statement to Reg for Common Stock
03 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Filing of 2023 Annual Report on Form 10-K
01 Apr 2024 //
GLOBENEWSWIRE
BioRestorative Therapies to Participate in the 36th Annual ROTH Conference
11 Mar 2024 //
GLOBENEWSWIRE
BioRestorative Announces Exercise of Warrants and Issuance of New Warrants
06 Feb 2024 //
GLOBENEWSWIRE
BioRestorative Receives a Notice of Allowance by USA Patent for Patent Related to Obesity Program
12 Dec 2023 //
GLOBENEWSWIRE
BioRestorative to Participate at ROTH MKM Healthcare Opportunities Conference
09 Oct 2023 //
GLOBENEWSWIRE
BioRestorative Enters into Supply Agreement with Evolutionary Biologics
12 Sep 2023 //
GLOBENEWSWIRE
BioRestorative Announces Activation of Northwell Health in Phase 2 Trial
08 Sep 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Receives Landmark License From New York State
21 Jul 2023 //
ACCESSWIRE
BioRestorative Therapies Announces $2.1 Million Registered Direct Offering
11 Jul 2023 //
GLOBENEWSWIRE
BioRestorative Therapies` Drug Candidate BRTX-100 Passes Safety Test
07 Jul 2023 //
ACCESSWIRE
BioRestorative Therapies Receives Unanimous Recommendation from DSMB
27 Jun 2023 //
GLOBENEWSWIRE
BioRestorative to Participate in the Healthcare Virtual Conference
16 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Announces Dosing Completion in Phase 2 Trial Targeting Chronic Lumbar Disc Disease
12 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Therapies to attend the Jefferies 2023 Healthcare Conference
01 Jun 2023 //
GLOBENEWSWIRE
BioRestorative Receives License from New York State Department of Health
31 May 2023 //
GLOBENEWSWIRE
BioRestorative Receives Notice of Allowance by the Japanese Patent & Trademark
15 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies and Northwell Health Enter into Agreement
08 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies, Inc. to participate at the EF Hutton Global Conference
04 May 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Completion of Patient its Ph2 of BRTX-100
24 Apr 2023 //
GLOBENEWSWIRE
BioRestorative to Seek FDA Approval to Expand the Application of BRTX-100
13 Mar 2023 //
GLOBENEWSWIRE
BioRestorative Therapies Receives Notice of Allowance by United States Patent
02 Mar 2023 //
GLOBENEWSWIRE
BioRestorative Announces Notice of Allowance by the European Patent Office
08 Feb 2023 //
GLOBENEWSWIRE
BioRestorative Announces SBIR Phase I Grant to Explore the Therapeutic Effects
06 Dec 2022 //
GLOBENEWSWIRE
BioRestorative Enters Agreement with Regenexx, Granting BRTX License Rights
05 Dec 2022 //
GLOBENEWSWIRE
BioRestorative to Participate at the RHK Capital Disruptive Growth Conference
29 Nov 2022 //
GLOBENEWSWIRE
BioRestorative CEO Lance Alstodt to be Interviewed on Famela
20 Oct 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Present at the Dawson James Securities 7th Small
28 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Participate in the Roth Inaugural Healthcare
27 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual GIC on
07 Sep 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Begins Enrollment in PII Trial for cLDD
30 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Announces Trial Contract with Second Site for PII Trial
22 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Announces Clinical Site Initiation for PII Trial to Treat cLDD
13 Jun 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Hosts Investigator Meeting for its BRTX-100 PII Trial
29 Apr 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Selects 10 Clinical Sites for PII Trial
18 Apr 2022 //
GLOBENEWSWIRE
BioRestorative Therapies Shows cGMP Cell Manufacturing Facility Certification
04 Apr 2022 //
GLOBENEWSWIRE
